Skip to main content
Premium Trial:

Request an Annual Quote

Codon Devices Reportedly Shuts Down

NEW YORK (GenomeWeb News) – Codon Devices is reportedly shutting down its operations, according to an article posted on website of The Boston Globe on Friday.

Calls to Codon were not returned to GenomeWeb Daily News to confirm the report.

The Cambridge, Mass.-based firm markets its synthetic biology products and design services, including its BioFab production platform, to clients in the pharmaceutical, biotechnology, institutional, and bioenergy fields. The BioFab platform combines informatics and proprietary algorithms, automated technology, and biochemical protocols for use in designing and building genetic sequences.

Codon raised $11 million in a round of private financing last year through some well-known life science venture capital firms including Alloy Ventures, Flagship Ventures, Highland Capital Partners, Khosla Ventures, Kleiner Perkins Caufield & Byers, and Tactics II Ventures. The company had raised $20 million in December 2006.

According to the Globe article, Codon's board decided last week to shut down operations after the firm failed to raise additional funds.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.